CARMA FUND I invests in early-stage companies and projects in Life Science and Healthcare, leveraging exclusive academic access, cross-sector expertise, and a strong European syndication network. The fund focuses on supporting innovative projects to bring them to market, addressing challenges in patient benefit and medical advancements with flexible investment modalities and long-term support.
Bevorzugte Reifephase für die erste Finanzierung.
Early-stage Life Science and Healthcare technologies, including therapeutics, diagnostics, medical devices, and digital health solutions.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...